Radulovic L - Search Results

1

Preclinical toxicity of a new oral anticancer drug, CI-994 (acetyldinaline), in rats and dogs.

Graziano MJ, Pilcher GD, Walsh KM, Kasali OB, Radulovic L. Graziano MJ, et al. Among authors: radulovic l. Invest New Drugs. 1997;15(4):295-310. doi: 10.1023/a:1005937502511. Invest New Drugs. 1997. PMID: 9547672

2

Chronic oral administration of CI-994: a phase 1 study.

Prakash S, Foster BJ, Meyer M, Wozniak A, Heilbrun LK, Flaherty L, Zalupski M, Radulovic L, Valdivieso M, LoRusso PM. Prakash S, et al. Among authors: radulovic l. Invest New Drugs. 2001;19(1):1-11. doi: 10.1023/a:1006489328324. Invest New Drugs. 2001. PMID: 11291827 Clinical Trial.

3

Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.

Radulovic LL, Türck D, von Hodenberg A, Vollmer KO, McNally WP, DeHart PD, Hanson BJ, Bockbrader HN, Chang T. Radulovic LL, et al. Drug Metab Dispos. 1995 Apr;23(4):441-8. Drug Metab Dispos. 1995. PMID: 7600909

4

Pharmacokinetics, mass balance, and induction potential of a novel GABA uptake inhibitor, CI-966 HCl, in laboratory animals.

Radulovic LL, Bockbrader HN, Chang T. Radulovic LL, et al. Pharm Res. 1993 Oct;10(10):1442-5. doi: 10.1023/a:1018915123542. Pharm Res. 1993. PMID: 8272405

5

Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor.

Radulovic LL, Cilla DD, Posvar EL, Sedman AJ, Whitfield LR. Radulovic LL, et al. J Clin Pharmacol. 1995 Oct;35(10):990-4. doi: 10.1002/j.1552-4604.1995.tb04015.x. J Clin Pharmacol. 1995. PMID: 8568017 Clinical Trial.

6

Measurement of CI-979 (a candidate drug for the treatment of age-related disorders of cognition) in human plasma by capillary gas chromatography with nitrogen-selective detection.

Windsor BL, Radulovic LL, Bockbrader HN, Chang T. Windsor BL, et al. Among authors: radulovic ll. J Chromatogr. 1993 Sep 22;619(2):315-8. doi: 10.1016/0378-4347(93)80123-l. J Chromatogr. 1993. PMID: 8263105

7

Identification of a pyridinium metabolite in human urine following a single oral dose of 1-[2-[bis[4-(trifluoromethyl)phenyl]methoxy]ethyl]- 1,2,5,6-tetrahydro-3-pyridinecarboxylic acid monohydrochloride, a gamma-aminobutyric acid uptake inhibitor.

Radulovic L, Woolf T, Bjorge S, Taylor C, Reily M, Bockbrader H, Chang T. Radulovic L, et al. Chem Res Toxicol. 1993 May-Jun;6(3):341-4. doi: 10.1021/tx00033a014. Chem Res Toxicol. 1993. PMID: 8318656

8

Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects.

Posvar EL, Radulovic LL, Cilla DD Jr, Whitfield LR, Sedman AJ. Posvar EL, et al. Among authors: radulovic ll. J Clin Pharmacol. 1996 Aug;36(8):728-31. doi: 10.1002/j.1552-4604.1996.tb04242.x. J Clin Pharmacol. 1996. PMID: 8877677 Clinical Trial.

9

Measurement of a new anticonvulsant, (S)-3-(aminomethyl)-5-methylhexanoic acid, in plasma and milk by high-performance liquid chromatography.

Windsor BL, Radulovic LL. Windsor BL, et al. Among authors: radulovic ll. J Chromatogr B Biomed Appl. 1995 Dec 1;674(1):143-8. doi: 10.1016/0378-4347(95)00300-8. J Chromatogr B Biomed Appl. 1995. PMID: 8749263

10

Oxicams: metabolic disposition in man and animals.

Woolf TF, Radulovic LL. Woolf TF, et al. Among authors: radulovic ll. Drug Metab Rev. 1989;21(2):255-76. doi: 10.3109/03602538909029942. Drug Metab Rev. 1989. PMID: 2517627 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page